These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 17394219)

  • 1. Usefulness of the disease activity scores for polymyalgia rheumatica for predicting glucocorticoid dose changes: a study of 243 scenarios.
    Binard A; De Bandt M; Berthelot JM; Saraux A;
    Arthritis Rheum; 2007 Apr; 57(3):481-6. PubMed ID: 17394219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validity of the polymyalgia rheumatica activity score in primary care practice.
    Binard A; Lefebvre B; De Bandt M; Berthelot JM; Saraux A;
    Ann Rheum Dis; 2009 Apr; 68(4):541-5. PubMed ID: 18477738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of the polymyalgia rheumatica activity score for diagnosing disease flares.
    Binard A; de Bandt M; Berthelot JM; Saraux A;
    Arthritis Rheum; 2008 Feb; 59(2):263-9. PubMed ID: 18240260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of the polymyalgia rheumatica activity score to glucocorticoid dosage adjustment in everyday practice.
    Cleuziou C; Binard A; De Bandt M; Berthelot JM; Saraux A
    J Rheumatol; 2012 Feb; 39(2):310-3. PubMed ID: 22174199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythrocyte sedimentation rate and C-reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: a prospective follow-up study.
    Cantini F; Salvarani C; Olivieri I; Macchioni L; Ranzi A; Niccoli L; Padula A; Boiardi L
    Semin Arthritis Rheum; 2000 Aug; 30(1):17-24. PubMed ID: 10966209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A disease activity score for polymyalgia rheumatica.
    Leeb BF; Bird HA
    Ann Rheum Dis; 2004 Oct; 63(10):1279-83. PubMed ID: 15361387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relapse in a population based cohort of patients with polymyalgia rheumatica.
    Kremers HM; Reinalda MS; Crowson CS; Zinsmeister AR; Hunder GG; Gabriel SE
    J Rheumatol; 2005 Jan; 32(1):65-73. PubMed ID: 15630727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute-phase reactants and the risk of relapse/recurrence in polymyalgia rheumatica: a prospective followup study.
    Salvarani C; Cantini F; Niccoli L; Macchioni P; Consonni D; Bajocchi G; Vinceti M; Catanoso MG; Pulsatelli L; Meliconi R; Boiardi L
    Arthritis Rheum; 2005 Feb; 53(1):33-8. PubMed ID: 15696567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The polymyalgia rheumatica activity score in daily use: proposal for a definition of remission.
    Leeb BF; Rintelen B; Sautner J; Fassl C; Bird HA
    Arthritis Rheum; 2007 Jun; 57(5):810-5. PubMed ID: 17530664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical management of polymyalgia rheumatica.
    Gonzalez-Gay MA; Agudo M; Martinez-Dubois C; Pompei O; Blanco R
    Expert Opin Pharmacother; 2010 May; 11(7):1077-87. PubMed ID: 20367535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EULAR response criteria for polymyalgia rheumatica: results of an initiative of the European Collaborating Polymyalgia Rheumatica Group (subcommittee of ESCISIT).
    Leeb BF; Bird HA; Nesher G; Andel I; Hueber W; Logar D; Montecucco CM; Rovensky J; Sautner J; Sonnenblick M
    Ann Rheum Dis; 2003 Dec; 62(12):1189-94. PubMed ID: 14644857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid effects on adrenal steroids and cytokine responsiveness in polymyalgia rheumatica and elderly onset rheumatoid arthritis.
    Sulli A; Montecucco CM; Caporali R; Cavagna L; Montagna P; Capellino S; Fazzuoli L; Seriolo B; Alessandro C; Secchi ME; Cutolo M
    Ann N Y Acad Sci; 2006 Jun; 1069():307-14. PubMed ID: 16855158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing polymyalgia rheumatica activity when C-reactive protein is unavailable or uninterpretable.
    Devauchelle-Pensec V; Saraux L; Berthelot JM; De Bandt M; Cornec D; Guellec D; Marhadour T; Jousse-Joulin S; Gouillou M; Saraux A
    Rheumatology (Oxford); 2018 Apr; 57(4):666-670. PubMed ID: 29346621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum amyloid A as a useful index of disease activity in polymyalgia rheumatica].
    Yamane T; Yamauchi H; Abe N; Torio N; Shimada R; Senba T; Imaizumi Y; Nomura T
    Ryumachi; 2003 Jun; 43(3):544-8. PubMed ID: 12910963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes, quality of life, and diagnostic uncertainty in the first year of polymyalgia rheumatica.
    Hutchings A; Hollywood J; Lamping DL; Pease CT; Chakravarty K; Silverman B; Choy EH; Scott DG; Hazleman BL; Bourke B; Gendi N; Dasgupta B
    Arthritis Rheum; 2007 Jun; 57(5):803-9. PubMed ID: 17530680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-body MRI of patients with polymyalgia rheumatica identifies a distinct subset with complete patient-reported response to glucocorticoids.
    Mackie SL; Pease CT; Fukuba E; Harris E; Emery P; Hodgson R; Freeston J; McGonagle D
    Ann Rheum Dis; 2015 Dec; 74(12):2188-92. PubMed ID: 26376658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoids and cardiovascular and cerebrovascular events in polymyalgia rheumatica.
    Maradit Kremers H; Reinalda MS; Crowson CS; Davis JM; Hunder GG; Gabriel SE
    Arthritis Rheum; 2007 Mar; 57(2):279-86. PubMed ID: 17330277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma fibrinogen along with patient-reported outcome measures enhances management of polymyalgia rheumatica: a prospective study.
    McCarthy EM; MacMullan PA; Al-Mudhaffer S; Madigan A; Donnelly S; McCarthy CJ; Molloy ES; Kenny D; McCarthy GM
    J Rheumatol; 2014 May; 41(5):931-7. PubMed ID: 24692520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymyalgia rheumatica.
    Salvarani C; Cantini F; Boiardi L; Hunder GG
    Best Pract Res Clin Rheumatol; 2004 Oct; 18(5):705-22. PubMed ID: 15454128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing classification criteria for polymyalgia rheumatica: comparison of views from an expert panel and wider survey.
    Dasgupta B; Salvarani C; Schirmer M; Crowson CS; Maradit-Kremers H; Hutchings A; Matteson EL;
    J Rheumatol; 2008 Feb; 35(2):270-7. PubMed ID: 18050370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.